What was the precise final concentration (µg a.i./mL) of each fungicide in the amended PDA?
Was the “recommended rate” diluted from a formulated product stock, and if so, what was the calculation to arrive at the a.i. concentration in the medium?
Given the differential performance of fresh (active mycelium) versus dry (dormant spore) formulations observed in your trials, how does the in vitro compatibility of spores (tested here) predict the in planta compatibility of the more effective fresh formulation?
